MYND Life Sciences Inc. MYNDF
Set alert
At close · Oct 30
- YTD
- 0.00%
- 1 year
- -41.30%
- Open
- 0.045
- Prev close
- 0.0081
- Mkt cap
- 387.32K
- Vol
- 7.92K
- Avg vol
- 0
- EPS
- -0.01
- P/E
- 0.00
More statistics
- Low
- 0.045
- High
- 0.0675
News
1 year ago newsfilecorp.com
MYND Life Sciences Announces Shares for Debt Transaction
Vancouver, British Columbia--(Newsfile Corp. - February 11, 2025) - MYND Life Sciences Inc. (CSE: MYND) (OTC Pink: MYNDF) ("MYND" or the "Company") a clinical-stage life sciences company committed to…
1 year ago newsfilecorp.com
MYND Life Sciences Announces the Issuance of 4,000,001 Shares at $0.71/share
Vancouver, British Columbia--(Newsfile Corp. - January 17, 2025) - MYND Life Sciences (CSE: MYND) (OTC Pink: MYNDF) ("MYND" or the "Company") a clinical-stage life sciences company committed to the…
1 year ago newsfilecorp.com
MYND Life Sciences Announces Successful Conclusion of Debenture Settlement Agreement and Leadership Transition
Vancouver, British Columbia--(Newsfile Corp. - January 10, 2025) - MYND Life Sciences (CSE: MYND) (OTC Pink: MYNDF) ("MYND" or the "Company") a clinical-stage life sciences company committed to the…
1 year ago newsfilecorp.com
MYND Life Sciences Announces Strategic Debt Reduction and New Board Member Appointment
Vancouver, British Columbia--(Newsfile Corp. - November 22, 2024) - MYND Life Sciences (CSE: MYND) (OTCQB: MYNDF) ("MYND" or the "Company"), a leader in mental health diagnostics and treatments,…
1 year ago newsfilecorp.com
MYND Life Sciences Announces Proposed Share Issuance to Remove Debenture and $3.440 M in debt on business
Vancouver, British Columbia--(Newsfile Corp. - November 12, 2024) - MYND Life Sciences (CSE: MYND) (OTCQB: MYNDF) ("MYND" or the "Company") a clinical-stage life sciences company committed to the…
2 years ago newsfilecorp.com
MYND Life Sciences Announces New Director & Update on the Proposed Merger with Cava Healthcare Inc.
Vancouver, British Columbia--(Newsfile Corp. - January 30, 2024) - MYND Life Sciences (CSE: MYND) (OTCQB: MYNDF) ("MYND" or the "Company") The Company is pleased to welcome Ms. Laurie Bakke who was…
2 years ago newsfilecorp.com
MYND Life Sciences Inc. Announces the Appointment of Mr. John Campbell as President and Chief Executive Officer
Vancouver, British Columbia--(Newsfile Corp. - December 5, 2023) - MYND Life Sciences (CSE: MYND) (OTCQB: MYNDF) ("MYND" or the "Company"), a pioneering biopharmaceutical research and development…
2 years ago newsfilecorp.com
Dr. Lyle Oberg Appointment as Board Chair of Alberta Health Services and Executive Chair of MYND Life Sciences
Vancouver, British Columbia--(Newsfile Corp. - December 4, 2023) - MYND Life Sciences (CSE: MYND) (OTCQB: MYNDF) ("MYND" or the "Company"), We are delighted to announce the appointment of Mynd Life…
3 years ago newsfilecorp.com
MYND Life Sciences Inc. Announces Non-Binding LOI to enable merger with Cava Healthcare Inc.
Potential merger to create new industry leader. Vancouver, British Columbia--(Newsfile Corp. - October 25, 2023) - MYND Life Sciences (CSE: MYND) (OTCQB: MYNDF) ("MYND" or the "Company"), a…
3 years ago newsfilecorp.com
MYND Life Sciences Announces Update on Payment Obligations Under Unsecured Convertible Debentures
MYND Life Sciences was formed to commercialize proprietary biomarker diagnostic tests and novel therapeutics for patients suffering from MDD, TRD and other neuro-inflammatory disorders Vancouver,…